Dina Masi
Chief Financial Officer · INTEGRATED BIOPHARMA INC
Individual
- 2024
- May 21, 2025
- 3
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Dina Masi's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Charles N. Mills - $74.80M in MDLN purchases and sales in the last 12 months
- Keith A. Meister - $74.03M in WGS purchases and sales in the last 12 months
- Warren B. Kanders - $73.88M in CDRE purchases and sales in the last 12 months
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- L1 Capital Pty Ltd - $72.66M in AVR purchases and sales in the last 12 months
- James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dina Masi?
Dina Masi is a corporate insider, tracked as Chief Financial Officer of INTEGRATED BIOPHARMA INC (INBP). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Dina Masi last file a Form 4?
The most recent primary Form 4 on record is dated 21 May 2025, one of 3 filings going back to 2024.
